Ganna Panasyuk

Title: Ganna Panasyuk: Innovator in mTOR Research

Introduction

Ganna Panasyuk is a notable inventor based in London, GB. She has made significant contributions to the field of molecular biology, particularly in the study of the mammalian target of rapamycin (mTOR) protein. Her innovative work has implications for understanding and treating diseases associated with mTOR dysregulation.

Latest Patents

Ganna Panasyuk holds a patent for a truncated variant of the mTOR protein, specifically mTORbeta. This invention encompasses nucleic acids encoding mTORbeta, antibodies against mTORbeta, and methods for producing and screening agents that modulate mTORbeta expression and activity. Furthermore, her patent outlines a method for treating diseases linked to aberrant mTORbeta expression through the administration of agents that alter mTOR activity and expression. She has 1 patent to her name.

Career Highlights

Throughout her career, Ganna has worked with prominent organizations such as UCL Business Plc and the Ludwig Institute for Cancer Research Limited. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific discoveries.

Collaborations

Ganna has collaborated with esteemed colleagues, including Ivan Nemazanyy and Alexander Zhyvoloup. These partnerships have enriched her research endeavors and fostered innovation in her field.

Conclusion

Ganna Panasyuk's contributions to mTOR research highlight her role as an influential inventor in the scientific community. Her work not only advances our understanding of critical biological processes but also opens avenues for potential therapeutic interventions.